Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Etfmg Treatments Testing and Advancements ETF (GERM)

Etfmg Treatments Testing and Advancements ETF (GERM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family ETF Managers Group
  • Assets Under Management 39,675,300
  • Shares Outstanding, K 1,400
  • 60-Month Beta 0.23
Trade GERM with:
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield 0.10 (0.36%)
  • Most Recent Dividend 0.001 on 12/28/21
  • Management Fee 0.68%
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 2.96% ( -20.12%)
  • Historical Volatility 30.34%
  • IV Percentile 3%
  • IV Rank 1.94%
  • IV High 92.81% on 01/27/21
  • IV Low 1.18% on 11/17/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 0
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 0
  • Open Int (30-Day) 0

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.80 +0.09%
on 01/21/22
37.29 -25.38%
on 12/22/21
-9.64 (-25.73%)
since 12/21/21
3-Month
27.80 +0.09%
on 01/21/22
40.53 -31.35%
on 11/30/21
-10.56 (-27.50%)
since 10/21/21
52-Week
27.80 +0.09%
on 01/21/22
46.06 -39.59%
on 08/10/21
-8.67 (-23.77%)
since 01/21/21

Most Recent Stories

More News
Biotech ETFs That Outperformed Last Week

Biotech ETFs was the biggest gainer last week.

JNJ : 165.64 (+0.24%)
PFE : 52.69 (-2.52%)
MRNA : 161.22 (-3.76%)
FBT : 144.49 (-0.70%)
PBE : 59.68 (-0.03%)
SBIO : 34.29 (-0.79%)
BBP : 41.38 (-0.52%)
GERM : 27.88 (-1.62%)
Healthcare Emerges as Best Sector of Last Week: 5 Top ETFs

Wall Street was downbeat last week with all indexes in the red. Still, Healthcare sector emerged as a key winner last week.

FBT : 144.49 (-0.70%)
PBE : 59.68 (-0.03%)
SBIO : 34.29 (-0.79%)
BBP : 41.38 (-0.52%)
GERM : 27.88 (-1.62%)
5 Best Sector ETFs of November

Though the broad markets ended the month in red, a few sector ETFs performed remarkably well.

ITB : 70.30 (+0.36%)
SOXX : 482.20 (+0.32%)
ESPO : 63.00 (-0.65%)
GERM : 27.88 (-1.62%)
VCAR : 13.47 (-3.51%)
Moderna ETFs Rallying on COVID-19 Vaccine News to Combat Omicron

Moderna has been rallying amid concerns surrounding the omicron variant, which has led to possibilities of a rise in demand for COVID-19 vaccines and boosters.

MRNA : 161.22 (-3.76%)
IBB : 129.72 (-0.71%)
BBH : 162.16 (-1.10%)
IDNA : 34.99 (-0.93%)
GERM : 27.88 (-1.62%)
Bet On COVID-Themed ETFs as New Cases Rise Globally

The remainder of 2021 is expected to continue reeling under the spurt in coronavirus cases. Thus, a COVID-themed ETF could be a wise choice.

GERM : 27.88 (-1.62%)
WFH : 67.02 (-0.70%)
VIRS : 31.50 (-0.67%)
EDUT : 8.14 (-1.57%)
EDOC : 14.56 (-0.61%)
Moderna ETFs to Rally on Positive COVID-19 Booster Shot News

Moderna is expected to gain approval for booster shots for its COVID-19 vaccine.

MRNA : 161.22 (-3.76%)
IBB : 129.72 (-0.71%)
BBH : 162.16 (-1.10%)
IDNA : 34.99 (-0.93%)
GERM : 27.88 (-1.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Fund Summary

The ETFMG Treatments Testing and Advancements ETF seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the Prime Treatments, Testing and Advancements Index.

See More

Key Turning Points

3rd Resistance Point 30.07
2nd Resistance Point 29.73
1st Resistance Point 29.03
Last Price 27.88
1st Support Level 27.99
2nd Support Level 27.65
3rd Support Level 26.95

See More

52-Week High 46.06
Fibonacci 61.8% 39.08
Fibonacci 50% 36.93
Fibonacci 38.2% 34.78
Last Price 27.88
52-Week Low 27.80

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar